The pharmacokinetics and safety of olaparib alone and with paclitaxel in Chinese patients with advanced solid tumour.

Trial Identifier:	D081BC00002
Sponsor:	AstraZeneca
NCTID::	NCT02430311
Start Date:	June 2015
Primary Completion Date:	July 2016
Condition:	Cancer - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
China	Beijing, China, 100021
China	Beijing, China, 100071
China	Hangzhou, China, 310003

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.